Short-Term Drop in Antibody Titer after the Third Dose of SARS-CoV-2 BNT162b2 Vaccine in Adults

Short-Term Drop in Antibody Titer after the Third Dose of SARS-CoV-2 BNT162b2 Vaccine in Adults

Little is known about the longevity of antibodies after a third dose of the mRNA-based SARS-CoV-2 vaccine BNT162b2 (BioNTech/Pfizer, Mainz, Germany). Therefore, serum antibody levels were evaluated after a third dose of BNT162b2 in healthy adult healthcare workers in Germany. These antibody levels d...

Full description

Bibliographic Details
Main Authors: Jonas Herzberg, Bastian Fischer, Heiko Becher, Ann-Kristin Becker, Human Honarpisheh, Salman Yousuf Guraya, Tim Strate, Cornelius Knabbe
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Vaccines
Subjects:
SARS-CoV-2
humoral immunity
antibody longevity
vaccination
BNT162b2
Online Access:https://www.mdpi.com/2076-393X/10/5/805

Internet

https://www.mdpi.com/2076-393X/10/5/805

Similar Items